Will Pfizer Slash Its >7% Yielding Dividend? I Wouldn't Rule It Out

Core Viewpoint - Pfizer is significantly impacted by the new healthcare policies introduced by the Trump administration, which may affect its dividend yield, currently over 7% [1]. Group 1: Company Analysis - Pfizer (NYSE: PFE) is described as the biggest victim of the recent healthcare policy changes [1]. - The article suggests that the dividend yield of Pfizer is currently greater than 7% [1]. Group 2: Industry Insights - The article emphasizes the importance of staying updated on stocks within the biotech, pharma, and healthcare sectors, highlighting key trends and catalysts that influence valuations [1]. - The investing group Haggerston BioHealth provides insights into product sales, forecasts for major pharmaceutical companies, and detailed financial analyses [1].